798 related articles for article (PubMed ID: 23797811)
1. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
4. Randomized Controlled Trial Comparing Drug-coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial.
Patel A; Irani FG; Pua U; Tay KH; Chong TT; Leong S; Chan ES; Tan GWL; Burgmans MC; Zhuang KD; Quek LHH; Kwan J; Damodharan K; Gogna A; Tan BP; Too CW; Chan SXJM; Chng SP; Yuan W; Tan BS
Radiology; 2021 Sep; 300(3):715-724. PubMed ID: 34227886
[TBL] [Abstract][Full Text] [Related]
5. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
[TBL] [Abstract][Full Text] [Related]
6. Randomized Controlled Trial of Acotec Drug-Eluting Balloon Versus Plain Balloon for Below-the-Knee Angioplasty.
Liistro F; Angioli P; Ventoruzzo G; Ducci K; Reccia MR; Ricci L; Falsini G; Scatena A; Pieroni M; Bolognese L
JACC Cardiovasc Interv; 2020 Oct; 13(19):2277-2286. PubMed ID: 32950416
[TBL] [Abstract][Full Text] [Related]
7. Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up.
Rosales OR; Mathewkutty S; Gnaim C
Catheter Cardiovasc Interv; 2008 Jul; 72(1):112-5. PubMed ID: 18412272
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
[TBL] [Abstract][Full Text] [Related]
10. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial.
Rastan A; Brechtel K; Krankenberg H; Zahorsky R; Tepe G; Noory E; Schwarzwälder U; Macharzina R; Schwarz T; Bürgelin K; Sixt S; Tübler T; Neumann FJ; Zeller T
J Am Coll Cardiol; 2012 Aug; 60(7):587-91. PubMed ID: 22878166
[TBL] [Abstract][Full Text] [Related]
12. Infrapopliteal drug-eluting stents for chronic limb ischemia.
Grant AG; White CJ; Collins TJ; Jenkins JS; Reilly JP; Ramee SR
Catheter Cardiovasc Interv; 2008 Jan; 71(1):108-11. PubMed ID: 18098211
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
[TBL] [Abstract][Full Text] [Related]
14. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs.
Giles KA; Pomposelli FB; Spence TL; Hamdan AD; Blattman SB; Panossian H; Schermerhorn ML
J Vasc Surg; 2008 Jul; 48(1):128-36. PubMed ID: 18502084
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
[TBL] [Abstract][Full Text] [Related]
16. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.
Spreen MI; Martens JM; Hansen BE; Knippenberg B; Verhey E; van Dijk LC; de Vries JP; Vos JA; de Borst GJ; Vonken EJ; Wever JJ; Statius van Eps RG; Mali WP; van Overhagen H
Circ Cardiovasc Interv; 2016 Feb; 9(2):e002376. PubMed ID: 26861113
[TBL] [Abstract][Full Text] [Related]
19. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome.
Schmidt A; Piorkowski M; Werner M; Ulrich M; Bausback Y; Bräunlich S; Ick H; Schuster J; Botsios S; Kruse HJ; Varcoe RL; Scheinert D
J Am Coll Cardiol; 2011 Sep; 58(11):1105-9. PubMed ID: 21884945
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: InPeria II trial.
Rand T; Lammer J; Rabbia C; Maynar M; Zander T; Jahnke T; Müller-Hülsbeck S; Scheinert D; Manninen HI
Radiology; 2011 Nov; 261(2):634-42. PubMed ID: 22012905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
